Broad antiretroviral defence by human APOBEC3G through lethal editing of nascent reverse transcripts

Isolation of a human gene that inhibits HIV-1 infection and is suppressed by the viral Vif protein

Sheehy, A. M., Gaddis, N., Choi, J. D., & Malim, M. H. (2002) · Nature · doi:10.1038/nature00939 · Cited by 2,407

Multiply attenuated lentiviral vector achieves efficient gene delivery in vivo

Zufferey, R., Nagy, D., Mandel, R. J., Naldini, L., & Trono, D. (1997) · Nature Biotechnology · doi:10.1038/nbt0997-871 · Cited by 1,977

A novel form of tissue-specific RNA processing produces apolipoprotein-B48 in intestine

Powell, L. M., Wallis, S. C., Pease, R. J., Edwards, Y. H., Knott, T. J., & Scott, J. (1987) · Cell · doi:10.1016/0092-8674(87)90510-1 · Cited by 1,039

Transcription-targeted DNA deamination by the AID antibody diversification enzyme

Chaudhuri, J., Tian, M., Khuong, C., Chua, K. F., Pinaud, E., & Alt, F. W. (2003) · Nature · doi:10.1038/nature01574 · Cited by 746

An Anthropoid-Specific Locus of Orphan C to U RNA-Editing Enzymes on Chromosome 22

Jarmuz, A., Chester, A., Bayliss, J., Gisbourne, J., Dunham, I., Scott, J., & Navaratnam, N. (2002) · Genomics · doi:10.1006/geno.2002.6718 · Cited by 711

A quantitative assay for HIV DNA integration in vivo

Butler, S. L., Hansen, M. S., & Bushman, F. D. (2001) · Nature Medicine · doi:10.1038/87979 · Cited by 695

RNA Editing Enzyme APOBEC1 and Some of Its Homologs Can Act as DNA Mutators

Harris, R. S., Petersen‐Mahrt, S. K., & Neuberger, M. S. (2002) · Molecular Cell · doi:10.1016/s1097-2765(02)00742-6 · Cited by 609

Molecular Cloning of an Apolipoprotein B Messenger RNA Editing Protein

Teng, B., Burant, C. F., & Davidson, N. O. (1993) · Science · doi:10.1126/science.8511591 · Cited by 536

Role of vif in replication of human immunodeficiency virus type 1 in CD4+ T lymphocytes

Gabuzda, D. H., Lawrence, K., Langhoff, E., Terwilliger, E., Dorfman, T., Haseltine, W. A., & Sodroski, J. (1992) · Journal of Virology · doi:10.1128/jvi.66.11.6489-6495.1992 · Cited by 444

Vif is crucial for human immunodeficiency virus type 1 proviral DNA synthesis in infected cells

von Schwedler, U. K., Song, J., Aiken, C., & Trono, D. (1993) · Journal of Virology · doi:10.1128/jvi.67.8.4945-4955.1993 · Cited by 441

Restriction factors in human retrovirus infections and the unprecedented case of CIITA as link of intrinsic and adaptive immunity against HTLV-1

Forlani, G., Shallak, M., Ramia, E., Tedeschi, A., & Accolla, R. S. (2019) · Retrovirology · doi:10.1186/s12977-019-0498-6 · Cited by 20

APOBEC3G Expression Is Restricted to Neurons in the Brains of Pigtailed Macaques

Hill, M. S., Mulcahy, E. R., Gomez, M. L., Pacyniak, E., Berman, N. E. J., & Stephens, E. B. (2006) · AIDS Research and Human Retroviruses · doi:10.1089/aid.2006.22.541 · Cited by 18

Anti-HIV Factors: Targeting Each Step of HIV's Replication Cycle

Colomer-Lluch, M., Gollahon, L., & Serra-Moreno, R. (2016) · Current HIV Research · doi:10.2174/1570162x14999160224094621 · Cited by 17

Characterization of the Cross-Species Transmission Potential for Porcine Deltacoronaviruses Expressing Sparrow Coronavirus Spike Protein in Commercial Poultry

Alhamo, M. A., Boley, P. A., Liu, M., Niu, X., Yadav, K. K., Lee, C. M., Saif, L. J., Wang, Q., & Kenney, S. P. (2022) · Viruses · doi:10.3390/v14061225 · Cited by 17

ADAR1 is a promising risk stratification biomarker of remnant liver recurrence after hepatic metastasectomy for colorectal cancer

Hata, N., Shigeyasu, K., Umeda, Y., Yano, S., Takeda, S., Yoshida, K., Fuji, T., Yoshida, R., Yasui, K., Umeda, H., et al. (2023) · Scientific Reports · doi:10.1038/s41598-023-29397-z · Cited by 17

Structural basis of HIV-1 Vif-mediated E3 ligase targeting of host APOBEC3H

Ito, F., Alvarez-Cabrera, A. L., Kim, K., Zhou, Z. H., & Chen, X. S. (2023) · Nature Communications · doi:10.1038/s41467-023-40955-x · Cited by 18

Differential Sensitivity of “Old” versus “New” APOBEC3G to Human Immunodeficiency Virus Type 1 Vif

Goila-Gaur, R., Khan, M. A., Miyagi, E., & Strebel, K. (2008) · Journal of Virology · doi:10.1128/jvi.01734-08 · Cited by 17

Hepatitis C Virus Infection Suppresses the Interferon Response in the Liver of the Human Hepatocyte Chimeric Mouse

Tsuge, M., Fujimoto, Y., Hiraga, N., Zhang, Y., Ohnishi, M., Kohno, T., Abe, H., Miki, D., Imamura, M., Takahashi, S., et al. (2011) · PLoS ONE · doi:10.1371/journal.pone.0023856 · Cited by 17

Functional characterization of Vif proteins from HIV-1 infected patients with different APOBEC3G haplotypes

Reddy, K., Ooms, M., Letko, M. C., Garrett, N., Simon, V. R., & Ndung’u, T. (2016) · AIDS · doi:10.1097/qad.0000000000001113 · Cited by 18

Multifaceted HIV‐1 Vif interactions with human E3 ubiquitin ligase and APOBEC3s

Hu, Y., Knecht, K. M., Shen, Q., & Xiong, Y. (2020) · FEBS Journal · doi:10.1111/febs.15550 · Cited by 18

Proteomic methods reveal cyclophilin a function as a host restriction factor against rotavirus infection

He, H., Mou, Z., Li, W., Fei, L., Tang, Y., Zhang, J., Yan, P., Chen, Z., Yang, X., Shen, Z., et al. (2013) · PROTEOMICS · doi:10.1002/pmic.201100579 · Cited by 17

A Variant Macaque-Tropic Human Immunodeficiency Virus Type 1 Is Resistant to Alpha Interferon-Induced Restriction in Pig-Tailed Macaque CD4+T Cells

Thippeshappa, R., Ruan, H., Wang, W., Zhou, P., & Kimata, J. T. (2013) · Journal of Virology · doi:10.1128/jvi.00338-13 · Cited by 17

Latent human cytomegalovirus enhances HIV-1 infection in CD34+ progenitor cells

Cheung, A. K. L., Huang, Y., Kwok, H., Chen, M., & Chen, Z. (2017) · Blood Advances · doi:10.1182/bloodadvances.2016000638 · Cited by 18

HIV-1 Escape from Small-Molecule Antagonism of Vif

Sharkey, M. E., Sharova, N. P., Mohammed, I., Huff, S. E., Kummetha, I. R., Singh, G., Rana, T. M., & Stevenson, M. (2019) · mBio · doi:10.1128/mbio.00144-19 · Cited by 17

Viral Manipulations of the Cullin-RING Ubiquitin Ligases

Liu, Y., & Tan, X. (2020) · Advances in experimental medicine and biology · doi:10.1007/978-981-15-1025-0_7 · Cited by 17

Adaptation, co-evolution, and human susceptibility to HIV-1 infection

Telenti, A. (2004) · Infection Genetics and Evolution · doi:10.1016/j.meegid.2004.11.001 · Cited by 17

Human genetic variability and HIV treatment response

Haas, D. W. (2006) · Current HIV/AIDS Reports · doi:10.1007/s11904-006-0018-x · Cited by 17

The incorporation of APOBEC3 proteins into murine leukemia viruses

Zhang, L., Li, X., Ma, J., Yu, L., Jiang, J., & Cen, S. (2008) · Virology · doi:10.1016/j.virol.2008.05.006 · Cited by 17

Cellular restriction factors affecting the early stages of HIV replication

Perez, O., & Hope, T. J. (2006) · Current HIV/AIDS Reports · doi:10.1007/s11904-006-0004-3 · Cited by 17

Comparison of G-to-A Mutation Frequencies Induced by APOBEC3 Proteins in H9 Cells and Peripheral Blood Mononuclear Cells in the Context of Impaired Processivities of Drug-Resistant Human Immunodeficiency Virus Type 1 Reverse Transcriptase Variants

Knoepfel, S. A., Salisch, N. C., Huelsmann, P. M., Rauch, P., Walter, H., & Metzner, K. J. (2008) · Journal of Virology · doi:10.1128/jvi.00554-08 · Cited by 17

Archived HIV-1 Drug Resistance Mutations: Role of Proviral HIV-1 DNA Genotype for the Management of Virological Responder People Living with HIV

Campagna, R., Nonne, C., Antonelli, G., & Turriziani, O. (2024) · Viruses · doi:10.3390/v16111697 · Cited by 16

Structural basis of sequence-specific RNA recognition by the antiviral factor APOBEC3G

Yang, H., Kim, K., Li, S., Pacheco, J., & Chen, X. S. (2022) · Nature Communications · doi:10.1038/s41467-022-35201-9 · Cited by 16

Ubiquitin-protein ligase E3A (UBE3A) mediation of viral infection and human diseases

Chaudhary, P., Proulx, J. M., & Park, I.-W. (2023) · Virus Research · doi:10.1016/j.virusres.2023.199191 · Cited by 16

Cellular Restriction Factors of Feline Immunodeficiency Virus

Zielonka, J., & Münk, C. (2011) · Viruses · doi:10.3390/v3101986 · Cited by 16

Increased expression of intrinsic antiviral genes in HLA-B*57-positive individuals

Raposo, R. A. S., Abdel‐Mohsen, M., Holditch, S. J., Kuebler, P., Cheng, R. G., Eriksson, E. M., Liao, W. J., Pillai, S. K., & Nixon, D. F. (2013) · Journal of Leukocyte Biology · doi:10.1189/jlb.0313150 · Cited by 17

NF-IL6 (C/EBPβ) induces HIV-1 replication by inhibiting cytidine deaminase APOBEC3G

Kinoshita, S. M., & Taguchi, S. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0807269105 · Cited by 16

Quantitative Analysis of Location‐ and Sequence‐Dependent Deamination by APOBEC3G Using Real‐Time NMR Spectroscopy

Furukawa, A., Sugase, K., Morishita, R., Nagata, T., Kodaki, T., Takaori‐Kondo, A., Ryo, A., & Katahira, M. (2014) · Angewandte Chemie International Edition · doi:10.1002/anie.201309940 · Cited by 16

Vif Proteins from Diverse Human Immunodeficiency Virus/Simian Immunodeficiency Virus Lineages Have Distinct Binding Sites in A3C

Zhang, Z., Gu, Q., Vasudevan, A. A. J., Jeyaraj, M., Schmidt, S., Zielonka, J., Perković, M., Heckel, J., Cichutek, K., Häussinger, D., et al. (2016) · Journal of Virology · doi:10.1128/jvi.01497-16 · Cited by 16

Viral subversion of APOBEC3s: Lessons for anti-tumor immunity and tumor immunotherapy

Borzooee, F., Asgharpour, M., Quinlan, E. M., Grant, M. D., & Larijani, M. (2017) · International Reviews of Immunology · doi:10.1080/08830185.2017.1403596 · Cited by 16

Moloney leukemia virus 10 (MOV10) inhibits the degradation of APOBEC3G through interference with the Vif-mediated ubiquitin–proteasome pathway

Chen, C., Ma, X., Hu, Q., Li, X., Huang, F., Zhang, J., Pan, T. S., Xia, J., Liu, C., & Zhang, H. (2017) · Retrovirology · doi:10.1186/s12977-017-0382-1 · Cited by 16

Methadone Inhibits Viral Restriction Factors and Facilitates HIV Infection in Macrophages

Wang, M.-R., Wu, D.-D., Luo, F., Zhong, C.-J., Wang, X., Zhu, N., Wu, Y.-J., Hu, H.-T., Feng, Y., Wang, X., et al. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.01253 · Cited by 16

Interactions of APOBEC3s with DNA and RNA

Maiti, A., Hou, S., Schiffer, C. A., & Matsuo, H. (2021) · Current Opinion in Structural Biology · doi:10.1016/j.sbi.2020.12.004 · Cited by 16

Viral resistance burden and APOBEC editing correlate with virological response in heavily treatment-experienced people living with multi-drug resistant HIV

Armenia, D., Santoro, M. M., Bellocchi, M. C., Carioti, L., Galli, L., Galli, A., Scutari, R., Salsi, E., Mussini, C., Sterrantino, G., et al. (2021) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2021.106492 · Cited by 16

HIV-1 trans-Infection Mediated by DCs: The Tip of the Iceberg of Cell-to-Cell Viral Transmission

Perez‐Zsolt, D., Regué, D. R., Muñoz‐Basagoiti, J., Aguilar‐Gurrieri, C., Clotet, B., Blanco, J., & Izquierdo‐Useros, N. (2021) · Pathogens · doi:10.3390/pathogens11010039 · Cited by 18

HIV-1 Vif: Counteracting Innate Antiretroviral Defenses

Cullen, B. R. (2003) · Molecular Therapy · doi:10.1016/j.ymthe.2003.08.010 · Cited by 16

APOBEC3 inhibits DEAD-END function to regulate microRNA activity

Ali, S., Karki, N., Bhattacharya, C., Zhu, R., MacDuff, D. A., Stenglein, M. D., Schumacher, A. J., Demorest, Z. L., Harris, R. S., Matin, A., et al. (2013) · BMC Molecular Biology · doi:10.1186/1471-2199-14-16 · Cited by 16

Simultaneous Mutations in CA and Vif of Maedi-Visna Virus Cause Attenuated Replication in Macrophages and Reduced Infectivity In Vivo

Guðmundsson, B., Jönsson, S., Ólafsson, O., Agnarsdóttir, G., Matthíasdóttir, S., Georgsson, G., Torsteinsdóttir, S., Svansson, V., Kristbjörnsdóttir, H. B., Franzdóttir, S. R., et al. (2005) · Journal of Virology · doi:10.1128/jvi.79.24.15038-15042.2005 · Cited by 16

Correlation of APOBEC3 in tumor tissues with clinico-pathological features and survival from hepatocellular carcinoma after curative hepatectomy.

Yang, Z., Lu, Y., Xu, Q., Zhuang, L., Tang, B., & Chen, X. (2015) · Europe PMC (PubMed Central) · Cited by 16

Identification of Two APOBEC3F Splice Variants Displaying HIV-1 Antiviral Activity and Contrasting Sensitivity to Vif*

Lassen, K. G., Wissing, S., Lobritz, M. A., Santiago, M. L., & Greene, W. C. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.154054 · Cited by 16

Guanine–adenine bias: a general property of retroid viruses that is unrelated to host-induced hypermutation

Müller, V., & Bonhoeffer, S. (2005) · Trends in Genetics · doi:10.1016/j.tig.2005.03.004 · Cited by 16

Discovery of L15 as a novel Vif PROTAC degrader with antiviral activity against HIV-1

Luo, D., Luo, R., Wang, W., Deng, R., Wang, S., Ma, X., Pu, C., Liu, Y., Zhang, H., Yu, S., et al. (2024) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2024.129880 · Cited by 15

Transposable elements may enhance antiviral resistance in HIV-1 elite controllers

Singh, M., Leddy, S. M., Iñiguez, L., Bendall, M. L., Nixon, D. F., & Feschotte, C. (2025) · Genome biology · doi:10.1186/s13059-025-03484-y · Cited by 16

Characterization of Anti-HIV Activity Mediated by R88-APOBEC3G Mutant Fusion Proteins in CD4 + T cells, Peripheral Blood Mononuclear Cells, and Macrophages

Ao, Z., Wang, X., Bello, A., Jayappa, K. D., Yu, Z., Fowke, K. R., He, X., Chen, X., Li, J., Kobinger, G., et al. (2010) · Human Gene Therapy · doi:10.1089/hum.2010.012 · Cited by 15

A Comparison of Two Single-Stranded DNA Binding Models by Mutational Analysis of APOBEC3G

Shindo, K., Li, M., Gross, P. J., Brown, W. L., Harjes, E., Lu, Y., Matsuo, H., & Harris, R. S. (2012) · Biology · doi:10.3390/biology1020260 · Cited by 15

Retroviral restriction and dependency factors in primates and carnivores

Fadel, H. J., & Poeschla, E. M. (2011) · Veterinary Immunology and Immunopathology · doi:10.1016/j.vetimm.2011.06.002 · Cited by 15

Molecular Structure and Biochemical Properties of the HCCH−Zn2+ Site in HIV-1 Vif

Giri, K., Scott, R. A., & Maynard, E. L. (2009) · Biochemistry · doi:10.1021/bi900677w · Cited by 15

Cellular kinases incorporated into HIV-1 particles: passive or active passengers?

Giroud, C., Chazal, N., & Briant, L. (2011) · Retrovirology · doi:10.1186/1742-4690-8-71 · Cited by 16

AID/APOBEC-network reconstruction identifies pathways associated with survival in ovarian cancer

Svoboda, M., Meshcheryakova, A., Heinze, G., Jaritz, M., Pils, D., Castillo‐Tong, D. C., Hager, G., Thalhammer, T., Jensen‐Jarolim, E., Birner, P., et al. (2016) · BMC Genomics · doi:10.1186/s12864-016-3001-y · Cited by 15

Mutagenic Activity of AID/APOBEC Deaminases in Antiviral Defense and Carcinogenesis

Shilova, O. N., Tsyba, D. L., & Shilov, E. S. (2022) · Molecular Biology · doi:10.1134/s002689332201006x · Cited by 15

The role of BST2/tetherin in feline retrovirus infection

Dietrich, I., Hosie, M. J., & Willett, B. J. (2011) · Veterinary Immunology and Immunopathology · doi:10.1016/j.vetimm.2011.06.020 · Cited by 15

Erroneous identification of APOBEC3-edited chromosomal DNA in cancer genomics

Suspène, R., Caval, V., Henry, M., Bouzidi, M. S., Wain–Hobson, S., & Vartanian, J. (2014) · British Journal of Cancer · doi:10.1038/bjc.2014.176 · Cited by 15

Mutations in the highly conserved SLQYLA motif of Vif in a simian–human immunodeficiency virus result in a less pathogenic virus and are associated with G-to-A mutations in the viral genome

Schmitt, K. P., Hill, M. S., Ruiz, A. J., Culley, N., Pinson, D. M., Wong, S. W., & Stephens, E. B. (2008) · Virology · doi:10.1016/j.virol.2008.10.013 · Cited by 15

Strategies to enhance the safety profile of xenotransplantation: minimizing the risk of viral zoonoses

Mattiuzzo, G., Scobie, L., & Takeuchi, Y. (2008) · Current Opinion in Organ Transplantation · doi:10.1097/mot.0b013e3282f7961e · Cited by 15

Host Genetics of HIV-1 Susceptibility

Telenti, A., & Bleiber, G. (2005) · Future Virology · doi:10.2217/17460794.1.1.55 · Cited by 15

Microscale synthesis of isotopically labeled R-[6-xH]N5,N10-methylene-5,6,7,8-tetrahydrofolate as a cofactor for thymidylate synthase

Agrawal, N., Mihai, C., & Kohen, A. (2004) · Analytical Biochemistry · doi:10.1016/j.ab.2004.01.029 · Cited by 15

HIV-1 Vif inhibits G to A hypermutations catalyzed by virus-encapsidated APOBEC3G to maintain HIV-1 infectivity

Wang, Y., Kinlock, B. L., Shao, Q., Turner, T. M., & Liu, B. (2014) · Retrovirology · doi:10.1186/preaccept-1021857188124542 · Cited by 15

Greater numbers of nucleotide substitutions are introduced into the genomic RNA of bovine viral diarrhea virus during acute infections of pregnant cattle than of non-pregnant cattle

Neill, J. D., Newcomer, B. W., Marley, M. S. D., Ridpath, J. F., & Givens, M. D. (2012) · Virology Journal · doi:10.1186/1743-422x-9-150 · Cited by 15

Vif and Apobec3G in the Innate Immune Response to HIV: a Tale of Two Proteins

Farrow, M. A., & Sheehy, A. M. (2008) · Future Microbiology · doi:10.2217/17460913.3.2.145 · Cited by 15

Cullin4A and Cullin4B Are Interchangeable for HIV Vpr and Vpx Action through the CRL4 Ubiquitin Ligase Complex

Sharifi, H. J., Furuya, A. K. M., Jellinger, R. M., Nekorchuk, M. D., & de Noronha, C. M. C. (2014) · Journal of Virology · doi:10.1128/jvi.00241-14 · Cited by 16

Association between APOBEC3H‐Mediated Demethylation and Immune Landscape in Head and Neck Squamous Carcinoma

Liu, Q., Luo, Y., Cao, R., Pan, X., Chen, X., Zhang, S.-Y., Zhang, W., Zhou, J., Cheng, B., & Ren, X. (2020) · BioMed Research International · doi:10.1155/2020/4612375 · Cited by 15

In–Depth Characterization of Viral Isolates from Plasma and Cells Compared with Plasma Circulating Quasispecies in Early HIV-1 Infection

Dalmau, J., Codoñer, F. M., Erkizia, I., Pino, M., Pou, C., Paredes, R., Clotet, B., Martínez‐Picado, J., & Prado, J. G. (2012) · PLoS ONE · doi:10.1371/journal.pone.0032714 · Cited by 15

A 30 KB region of the Epstein-Barr virus genome is colinear with the rearranged human immunoglobulin gene loci: Implications for a “Ping-Pong Evolution” model for persisting viruses and their hosts

Niller, H.-H., Salamon, D., Rahmann, S., Ilg, K., Koroknai, A., Bánáti, F., Schwarzmann, F., Wolf, H. J., & Minárovits, J. (2004) · Acta Microbiologica et Immunologica Hungarica · doi:10.1556/amicr.51.2004.4.7 · Cited by 15

Advances in Understanding the Coupling of DNA Base Modifying Enzymes to Processes Involving Base Excision Repair

Wyatt, M. D. (2013) · Advances in cancer research · doi:10.1016/b978-0-12-407190-2.00002-2 · Cited by 14

Intracellular detection of differential APOBEC3G, TRIM5alpha, and LEDGF/p75 protein expression in peripheral blood by flow cytometry

Mous, K., Jennes, W., Roo, A. D., Pintelon, I., Kestens, L., & Ostade, X. V. (2011) · Journal of Immunological Methods · doi:10.1016/j.jim.2011.06.028 · Cited by 14

HPV induction of APOBEC3 enzymes mediate overall survival and response to cisplatin in head and neck cancer

Conner, K. L., Shaik, A. N., Ekinci, E., Kim, S., Ruterbusch, J. J., Coté, M. L., & Patrick, S. M. (2020) · DNA repair · doi:10.1016/j.dnarep.2020.102802 · Cited by 14

Synthesis and antiviral activity of substituted bisaryl amide compounds as novel influenza virus inhibitors

Hao, L.-H., Li, Y., He, W., Wang, H., Shan, G., Jiang, J., Li, Y., & Li, Z. (2012) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2012.07.008 · Cited by 14

Catalytic Analysis of APOBEC3G Involving Real-Time NMR Spectroscopy Reveals Nucleic Acid Determinants for Deamination

Kamba, K., Nagata, T., & Katahira, M. (2015) · PLoS ONE · doi:10.1371/journal.pone.0124142 · Cited by 14

HIV-1 envelope glycoprotein stimulates viral transcription and increases the infectivity of the progeny virus through the manipulation of cellular machinery

Ran, X., Ao, Z., Trajtman, A., Xu, W. W., Kobinger, G., Keynan, Y., & Yao, X. (2017) · Scientific Reports · doi:10.1038/s41598-017-10272-7 · Cited by 15

Dual role of the chromatin-binding factor PHF13 in the pre- and post-integration phases of HIV-1 replication

Hofmann, S., Dehn, S., Businger, R., Bolduan, S., Schneider, M., Debyser, Z., Brack‐Werner, R., & Schindler, M. (2017) · Open Biology · doi:10.1098/rsob.170115 · Cited by 17

CLIP-related methodologies and their application to retrovirology

Bieniasz, P. D., & Kutluay, S. B. (2018) · Retrovirology · doi:10.1186/s12977-018-0417-2 · Cited by 14

Expression of APOBEC3G in kidney cells

Komohara, Y., Suekane, S., Noguchi, M., Matsuoka, K., Yamada, A., & Itoh, K. (2006) · Tissue Antigens · doi:10.1111/j.1399-0039.2006.00725.x · Cited by 14

Double-stranded RNA-specific adenosine deaminase 1 (ADAR1) promotes EIAV replication and infectivity

Tang, Y.-D., Lei, N., Fu, L.-H., Yang, F., Zhu, C.-H., Li, T., Li, Q., Wang, J., Li, Z., Wang, X., et al. (2015) · Virology · doi:10.1016/j.virol.2014.12.038 · Cited by 14

Activation of the glucocorticoid receptor releases unstimulated PBMCs from an early block in HIV-1 replication

Wiegers, K. J., Schwarck-Kokarakis, D., Reimer, R., & Bohn, W. (2008) · Virology · doi:10.1016/j.virol.2008.01.037 · Cited by 14

Host cell restriction factors of equine infectious anemia virus

Wang, X., Zhang, X., Ma, W., Li, J., & Wang, X. (2023) · Virologica Sinica · doi:10.1016/j.virs.2023.07.001 · Cited by 13

APOBEC3G-Augmented Stem Cell Therapy to Modulate HIV Replication: A Computational Study

Hosseini, I., & Gabhann, F. M. (2013) · PLoS ONE · doi:10.1371/journal.pone.0063984 · Cited by 13

Structural Determinants of the APOBEC3G N-Terminal Domain for HIV-1 RNA Association

Fukuda, H., Li, S., Sardo, L., Smith, J. L., Yamashita, K., Sarca, A. D., Shirakawa, K., Standley, D. M., Takaori‐Kondo, A., & Izumi, T. (2019) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2019.00129 · Cited by 13

Sustained high expression of multiple APOBEC3 cytidine deaminases in systemic lupus erythematosus

Perez-Bercoff, D., Laude, H., Lemaire, M., Hunewald, O. E., Thiers, V., Vignuzzi, M., Blanc, H., Poli, A., Amoura, Z., Caval, V., et al. (2021) · Scientific Reports · doi:10.1038/s41598-021-87024-1 · Cited by 13

The human endogenous retrovirus K(HML-2) has a broad envelope-mediated cellular tropism and is prone to inhibition at a post-entry, pre-integration step

Kramer, P., Lausch, V., Volkwein, A., Hanke, K., Höhn, O., & Bannert, N. (2015) · Virology · doi:10.1016/j.virol.2015.10.014 · Cited by 14

Molecular Evolution of HIV-1 CRF01_AE Env in Thai Patients

Boonchawalit, S., Jullaksorn, D., Uttiyoung, J., Yowang, A., Krathong, N., Chautrakul, S., Yamashita, A., Ikuta, K., Roobsoong, A., Kanitvittaya, S., et al. (2011) · PLoS ONE · doi:10.1371/journal.pone.0027098 · Cited by 13

Interleukin-2 Inhibits HIV-1 Replication in Some Human T Cell Lymphotrophic Virus-1-infected Cell Lines via the Induction and Incorporation of APOBEC3G into the Virion

Oguariri, R. M., Dai, L., Adelsberger, J. W., Rupert, A. W., Stevens, R. A., Yang, J., Huang, D.-W., Lempicki, R. A., Zhou, M., Baseler, M., et al. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.m113.468975 · Cited by 14

Multiple Inhibitory Factors Act in the Late Phase of HIV-1 Replication: a Systematic Review of the Literature

Gélinas, J., Gill, D. R., & Hyde, S. C. (2018) · Microbiology and Molecular Biology Reviews · doi:10.1128/mmbr.00051-17 · Cited by 14

Generation of Genomic Alteration from Cytidine Deamination

Liu, X., & Meng, F. (2018) · Advances in experimental medicine and biology · doi:10.1007/978-981-13-0593-1_5 · Cited by 13

Polymorphisms of the cytidine deaminase APOBEC3F have different HIV-1 restriction efficiencies

Mohammadzadeh, N., Follack, T. B., Love, R. P., Stewart, K., Sanche, S. E., & Chelico, L. (2018) · Virology · doi:10.1016/j.virol.2018.11.004 · Cited by 14

Characterization of an A3G-VifHIV-1-CRL5-CBFβ Structure Using a Cross-linking Mass Spectrometry Pipeline for Integrative Modeling of Host–Pathogen Complexes

Kaake, R. M., Echeverria, I., Kim, S. J., Dollen, J. V., Chesarino, N. M., Feng, Y., Yu, C., Ta, H. M., Chelico, L., Huang, L., et al. (2021) · Molecular & Cellular Proteomics · doi:10.1016/j.mcpro.2021.100132 · Cited by 13

Synthesis and antiviral activity of a series of novel N-phenylbenzamide and N-phenylacetophenone compounds as anti-HCV and anti-EV71 agents

Jiang, Z., Wang, H., Li, Y., Peng, Z., Li, Y., & Li, Z. (2015) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2015.03.013 · Cited by 13

APOBEC3G Expression Is Restricted to Epithelial Cells of the Proximal Convoluted Tubules and Is Not Expressed in the Glomeruli of Macaques

Hill, M. S., Ruiz, A. J., Gomez, L. M., Miller, J.-M., Berman, N. E. J., & Stephens, E. B. (2006) · Journal of Histochemistry & Cytochemistry · doi:10.1369/jhc.6a7054.2006 · Cited by 13

Abrogation of Vif function by peptide derived from the N-terminal region of the human immunodeficiency virus type 1 (HIV-1) protease

Hutoran, M., Britan‐Rosich, E., Baraz, L., Blumenzweig, I., Steinitz, M. O., & Kotler, M. (2004) · Virology · doi:10.1016/j.virol.2004.09.029 · Cited by 13

APOBEC3 enzymes mediate efficacy of cisplatin and are epistatic with base excision repair and mismatch repair in platinum response

Conner, K. L., Shaik, A. N., Marshall, K. A., Floyd, A. M., Ekinci, E., Lindquist, J., Sawant, A., Lei, W. H., Adolph, M. B., Chelico, L., et al. (2020) · NAR Cancer · doi:10.1093/narcan/zcaa033 · Cited by 12

The Intricate Interplay between APOBEC3 Proteins and DNA Tumour Viruses

Lovšin, N., Gangupam, B., & Bergant, M. (2024) · Pathogens · doi:10.3390/pathogens13030187 · Cited by 12

Novel mechanistic insights – A brand new Era for anti-HBV drugs

Lyu, W., Qin, H., Li, Q., Lu, D., Shi, C., Zhao, K., Zhang, S., Yu, R., Zhang, H., Zhou, X., et al. (2024) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2024.116854 · Cited by 12

The type I interferon response during viral infections: a “SWOT” analysis

Gaajetaan, G. R., Bruggeman, C. A., & Stassen, F. R. M. (2011) · Reviews in Medical Virology · doi:10.1002/rmv.713 · Cited by 12

Mapping the Vif–A3G interaction using peptide arrays: A basis for anti-HIV lead peptides

Reingewertz, T. H., Britan‐Rosich, E., Rotem‐Bamberger, S., Viard, M., Jacobs, A., Miller, A. R., Lee, J. Y., Hwang, J., Blumenthal, R., Kotler, M., et al. (2013) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2013.03.001 · Cited by 12

Genome Instability in DNA Viruses

Sanjuán, R., Pereira-Gómez, M., & Risso-Ballester, J. (2016) · Elsevier eBooks · doi:10.1016/b978-0-12-803309-8.00003-3 · Cited by 14

APOBEC3 Host Restriction Factors of HIV-1 Can Change the Template Switching Frequency of Reverse Transcriptase

Adolph, M. B., Ara, A., & Chelico, L. (2019) · Journal of Molecular Biology · doi:10.1016/j.jmb.2019.02.015 · Cited by 12

A Protein Antagonist of Activation-Induced Cytidine Deaminase Encoded by a Complex Mouse Retrovirus

Singh, G. B., Byun, H., Ali, A. F., Medina, F., Wylie, D., Shivram, H., Nash, A. K., Lozano, M. M., & Dudley, J. P. (2019) · mBio · doi:10.1128/mbio.01678-19 · Cited by 12

Human cell-dependent, directional, time-dependent changes in the mono- and oligonucleotide compositions of SARS-CoV-2 genomes

Iwasaki, Y., Abe, T., & Ikemura, T. (2021) · BMC Microbiology · doi:10.1186/s12866-021-02158-6 · Cited by 12

Temporal trend of drug-resistance and APOBEC editing in PBMC genotypic resistance tests from HIV-1 infected virologically suppressed individuals

Armenia, D., Gagliardini, R., Alteri, C., Svicher, V., Cento, V., Borghi, V., Vergori, A., Cicalini, S., Forbici, F., Fabeni, L., et al. (2023) · Journal of Clinical Virology · doi:10.1016/j.jcv.2023.105551 · Cited by 12

The Evolution of Resistance to Simian Immunodeficiency Virus (SIV): A Review

Locatelli, S., McKean, K. A., Clee, P. R. S., & Gonder, M. K. (2014) · International Journal of Primatology · doi:10.1007/s10764-014-9763-7 · Cited by 13

HIV-1-associated PKA acts as a cofactor for genome reverse transcription

Giroud, C., Chazal, N., Gay, B., Eldin, P., Brun, S., & Briant, L. (2013) · Retrovirology · doi:10.1186/1742-4690-10-157 · Cited by 12

BROAD ANTIRETROVIRAL DEFENSE BY HUMAN APOBEC3G THROUGH LETHAL EDITING OF NASCENT REVERSE TRANSCRIPTS

Church, J. A. (2004) · PEDIATRICS · doi:10.1542/peds.114.s1.552a

Death and the retrovirus

Vartanian, J., Sommer, P., & Wain–Hobson, S. (2003) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2003.08.008 · Cited by 36

The Role of the APOBEC3 Family of Cytidine Deaminases in Innate Immunity, G-to-A Hypermutation, and Evolution of Retroviruses

Santiago, M. L., & Greene, W. C. (2008) · Elsevier eBooks · doi:10.1016/b978-0-12-374153-0.00008-4 · Cited by 11

Cytidine Deamination of Retroviral DNA by Diverse APOBEC Proteins

Bishop, K. N., Holmes, R. K., Sheehy, A. M., Davidson, N. O., Cho, S., & Malim, M. H. (2004) · Current Biology · doi:10.1016/j.cub.2004.06.057 · Cited by 613

[Advances in the study of molecular mechanism of APOBEC3G anti-HIV-1].

Fan, B., Cen, S., & Jiang, J.-D. (2008) · PubMed